Aberrant alternative splicing is a hallmark of cancer, yet the underlying regulatory programs that control this process remain largely unknown. Here, we report a systematic effort to decipher the RNA structural code that shapes pathological splicing during breast cancer metastasis. We discovered a previously unknown structural splicing enhancer that is enriched near cassette exons with increased inclusion in highly metastatic cells. We show that the spliceosomal protein small nuclear ribonucleoprotein polypeptide A' (SNRPA1) interacts with these enhancers to promote cassette exon inclusion. This interaction enhances metastatic lung colonization and cancer cell invasion, in part through SNRPA1-mediated regulation of PLEC alternative splicing...
Metastatic cells exhibit an extraordinary phenotypic plasticity, not only in adapting to unfamiliar ...
Recent progress in global sequence and microarray data analy sis has revealed the increasing complex...
The functional capacity of cells is defined by the transcriptome. Many recent studies have identifie...
Splicing factors (SFs) act in dynamic macromolecular complexes to modulate RNA processing. To unders...
RNA splicing plays a central role in cell regulation, development, and disease progression, but the ...
Pre-messenger RNA splicing is a fine-tuned process that generates multiple functional variants from ...
Background: Breast cancer is the second most frequent type of cancer affecting women. We are increas...
BackgroundTriple negative breast cancer (TNBC) is an aggressive subtype of breast cancer with limite...
In breast cancer patients, tumor metastases at distant sites are the main cause of death. However, t...
Aberrant profiles of pre-mRNA splicing are frequently observed in cancer. At the molecular level, an...
Alternative splicing is a major contributor to transcriptome and proteome diversity in eukaryotes. C...
Alternative splicing is a tightly regulated process whereby non-coding sequences of pre-mRNA are rem...
Aberrant alternative splicing (AS) is a hallmark of cancer and a potential target for novel anti-can...
The epithelial-mesenchymal transition (EMT) is a fundamental developmental process that is abnormall...
Defects in alternative splicing are frequently found in human tumors and result either from mutation...
Metastatic cells exhibit an extraordinary phenotypic plasticity, not only in adapting to unfamiliar ...
Recent progress in global sequence and microarray data analy sis has revealed the increasing complex...
The functional capacity of cells is defined by the transcriptome. Many recent studies have identifie...
Splicing factors (SFs) act in dynamic macromolecular complexes to modulate RNA processing. To unders...
RNA splicing plays a central role in cell regulation, development, and disease progression, but the ...
Pre-messenger RNA splicing is a fine-tuned process that generates multiple functional variants from ...
Background: Breast cancer is the second most frequent type of cancer affecting women. We are increas...
BackgroundTriple negative breast cancer (TNBC) is an aggressive subtype of breast cancer with limite...
In breast cancer patients, tumor metastases at distant sites are the main cause of death. However, t...
Aberrant profiles of pre-mRNA splicing are frequently observed in cancer. At the molecular level, an...
Alternative splicing is a major contributor to transcriptome and proteome diversity in eukaryotes. C...
Alternative splicing is a tightly regulated process whereby non-coding sequences of pre-mRNA are rem...
Aberrant alternative splicing (AS) is a hallmark of cancer and a potential target for novel anti-can...
The epithelial-mesenchymal transition (EMT) is a fundamental developmental process that is abnormall...
Defects in alternative splicing are frequently found in human tumors and result either from mutation...
Metastatic cells exhibit an extraordinary phenotypic plasticity, not only in adapting to unfamiliar ...
Recent progress in global sequence and microarray data analy sis has revealed the increasing complex...
The functional capacity of cells is defined by the transcriptome. Many recent studies have identifie...